Literature DB >> 30423203

Entinostat finds a path: A new study elucidates effects of the histone deacetylase inhibitor on the immune system.

Ira Surolia1, Susan E Bates1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30423203     DOI： 10.1002/cncr.31766

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells.

Authors:  Eunnara Cho; Andrea Rowan-Carroll; Andrew Williams; J Christopher Corton; Heng-Hong Li; Albert J Fornace; Cheryl A Hobbs; Carole L Yauk
Journal:  Arch Toxicol       Date:  2021-03-26       Impact factor: 6.168

2.  Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma.

Authors:  Vijay G Ramakrishnan; Kevin C Miller; Elaine P Macon; Teresa K Kimlinger; Jessica Haug; Sanjay Kumar; Wilson I Gonsalves; S Vincent Rajkumar; Shaji K Kumar
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

Review 3.  Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities.

Authors:  Meilan Hu; Fule He; Erik W Thompson; Kostya Ken Ostrikov; Xiaofeng Dai
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.